Mentor Worldwide

Last updated
Mentor Worldwide LLC
Company type Subsidiary
Industry Medical equipment
Founded1969;55 years ago (1969), in Minneapolis, Minnesota, US
Headquarters Santa Barbara, California, U.S.
Key people
David J. Wilson (CEO) [1]
Edward S. Northup (COO)
Michael O'Neill (CFO)
Products ContourProfile Gel breast implants
MemoryGel breast implants
NIA 24 skincare
See complete products listing.
RevenueIncrease2.svg$302 million USD (2007)
Increase2.svg$57.6 million USD (2007) [2]
Number of employees
2,000 (2007)
Parent Ethicon
Website mentorwwllc.com

Mentor Worldwide LLC [3] is an American company that supplies surgical aesthetics products to plastic surgeons. The company is based in Santa Barbara, California. It produces one of two silicone gel breast implants. Titled MemoryGel, the product was approved by the U.S. Food and Drug Administration (FDA) on November 17, 2006. The other FDA-approved products are developed by competitors Allergan and Sientra. Mentor also produces a range of lipoplasty equipment for liposuction procedures as well as a Niacin-based skincare product line called NIA 24.

Contents

History

Mentor Corporation was founded in Minneapolis, Minnesota in 1969 by Christopher Conway, Eugene Glover, and Thomas Hauser. [4] [5] Mentor went public in 1970 and its first product line consisted of electronic laboratory instruments for the detection and measurement of the electrical activity of nerve cells and neural systems. Special urethral catheters for the treatment of urinary retention were introduced in 1975.[ citation needed ]

After acquiring the Heyer-Schulte division of American Hospital Supply in 1984. [6] Heyer Schulte manufactured implantable products. [6] In 1985, Mentor moved its headquarters to Santa Barbara, California. [5]

On Jan 23, 2009, Mentor was acquired by Johnson & Johnson, [7] [8] and is a stand-alone business unit reporting through Ethicon, Inc., a Johnson & Johnson company and provider of suture, mesh, hemostats, and other products for surgical procedures. Johnson & Johnson company markets its breast implant products in India with the name MentorConfidence.

Notes and references

  1. "California Healthcare Institute Biography: David J. Wilson". Archived from the original on 2013-06-19.
  2. "Mentor Corporation 2007 Annual Report View" (PDF). Retrieved 2008-06-12.
  3. "Mentor Capital (MNTR) and Its Peers Head to Head Comparison". 24 April 2022.
  4. "Chief Executive of Mentor Quits". Los Angeles Times. 2000-09-29. Retrieved 2020-11-10.
  5. 1 2 Black, Sam (3 July 2006). "Coloplast moving to Minneapolis". Minneapolis/St. Paul Business Journal.
  6. 1 2 Morris, Steven (15 February 1994). "BAXTER OKS $556 MILLION IMPLANT SETTLEMENT SHARE". chicagotribune.com. Retrieved 2020-11-10.
  7. "J&J to buy breast implant firm Mentor for $1.1 billion". Reuters. 2008-12-01. Retrieved 2020-01-29.
  8. "Johnson & Johnson Buys Medical Device Maker". The New York Times. 2008-12-01. ISSN   0362-4331 . Retrieved 2020-01-29.

Related Research Articles

<span class="mw-page-title-main">Plastic surgery</span> Medical surgical specialty

Plastic surgery is a surgical specialty involving the restoration, reconstruction, or alteration of the human body. It can be divided into two main categories: reconstructive surgery and cosmetic surgery. Reconstructive surgery includes craniofacial surgery, hand surgery, microsurgery, and the treatment of burns. While reconstructive surgery aims to reconstruct a part of the body or improve its functioning, cosmetic surgery aims to improve the appearance of it. A comprehensive definition of plastic surgery has never been established, because it has no distinct anatomical object and thus overlaps with practically all other surgical specialties. An essential feature of plastic surgery is that it involves the treatment of conditions that require or may require tissue relocation skills.

<span class="mw-page-title-main">Johnson & Johnson</span> American multinational pharmaceutical and consumer goods corporation

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.

<span class="mw-page-title-main">Breast augmentation</span> Surgical procedure

Breast augmentation and augmentation mammoplasty is a cosmetic surgery technique using breast-implants and fat-graft mammoplasty techniques to increase the size, change the shape, and alter the texture of the breasts. Although in some cases augementation mammoplasty is applied to correct congenital defects of the breasts and the chest wall in other cases it is used purely as a cosmetic surgery, primary breast augmentation changes the aesthetics – of size, shape, and texture – of healthy breasts.

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line.

<span class="mw-page-title-main">Dow Corning</span> Multinational corporation

Dow Corning Corporation, was an American multinational corporation headquartered in Midland, Michigan, United States, and was originally established as a joint venture between The Dow Chemical Company and Corning Incorporated. In 2016, Dow bought out Corning, making Dow Corning a 100% Dow subsidiary. After a brief existence as a DowDuPont-owned company, Dow spun out from DowDuPont on April 1, 2019. The new company, Dow Silicones Corporation, which is wholly owned by Dow, specializes in silicone and silicon-based technology, and is the largest silicone product producer in the world.

<span class="mw-page-title-main">David A. Kessler</span> American pediatrician & attorney (born 1951)

David Aaron Kessler is an American pediatrician, attorney, author, and administrator serving as Chief Science Officer of the White House COVID-19 Response Team since 2021. Kessler was the commissioner of the Food and Drug Administration (FDA) from November 8, 1990, to February 28, 1997. He co-chaired the Biden-Harris transition’s COVID-19 Advisory Board from November 2020 to January 2021 and was the head of Operation Warp Speed, the U.S. government program to accelerate the development of COVID-19 vaccines and other treatments, from January to February 2021.

<span class="mw-page-title-main">Neuticles</span> Prosthetic testicular implants for domestic animals

Neuticles are prosthetic testicular implants for neutered dogs and other domestic animals. The implants may be made of polypropylene or silicone.

<span class="mw-page-title-main">Allergan, Inc.</span> Former American conglomerate

Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970. It ceased operation in 2015 when it was acquired by Irish-based Actavis plc, who then renamed the group as Allergan plc.

<span class="mw-page-title-main">Capsular contracture</span> Response of the immune system to foreign materials in the human body

Capsular contracture is a response of the immune system to foreign materials in the human body. Medically, it occurs mostly in context of the complications from breast implants and artificial joint prosthetics.

<span class="mw-page-title-main">Breast implant</span> Prosthesis used to change the size, shape, and contour of a persons breast

A breast implant is a prosthesis used to change the size, shape, and contour of a person's breast. In reconstructive plastic surgery, breast implants can be placed to restore a natural looking breast following a mastectomy, to correct congenital defects and deformities of the chest wall or, cosmetically, to enlarge the appearance of the breast through breast augmentation surgery.

<span class="mw-page-title-main">Polypropylene breast implant</span> Continuously expanding breast implant

Polypropylene breast implants, also known as string breast implants, are a form of breast implant using polypropylene developed by Gerald W. Johnson. Due to a number of medical complications, the device has not been approved in the European Union or the United States.

Johnson & Johnson Vision (JJV) is a subsidiary of Johnson & Johnson and is composed of two divisions, Johnson & Johnson Surgical Vision and Johnson & Johnson Vision Care. Services include Intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastic, Microkeratomes and related products used in cataract and refractive surgery.

Medical grade silicones are silicones tested for biocompatibility and are appropriate to be used for medical applications. In the United States, the Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) regulates devices implanted into the body. It does not regulate materials other than certain dental materials. The FDA regulate silicones used in food contact under the auspices of the Center for Food Safety and Nutrition (CFSAN) and for use in pharmaceuticals under the auspices of the Center for Drug Evaluation and Research (CDER).

Trans-umbilical breast augmentation (TUBA) is a type of breast augmentation in which breast implants are placed through an incision at the navel rather than the chest.

Susan Kolb is a medical doctor in Atlanta, Georgia, and the author of The Naked Truth about Breast Implants: From Harm to Healing. Her area of specialization is plastic and reconstructive surgery. Kolb is a medical authority on the complications arising from breast implants, and has been an active voice in the debate about the safety of breast implant devices since 1996. She has treated over 2,000 women suffering from breast implant disease and related systemic immune disorders.

<span class="mw-page-title-main">Poly Implant Prothèse</span> Defunct French company

Poly Implant Prothèse (PIP) was a French company founded in 1991 that produced silicone gel breast implants. The company was preemptively liquidated in 2010 following the revelation that they had been illegally manufacturing and selling breast implants made from cheaper industrial-grade silicone since 2001.

<span class="mw-page-title-main">Bair Hugger</span> Convective temperature management system

The Bair Hugger system is a convective temperature management system used in a hospital or surgery center to maintain a patient's core body temperature. The Bair Hugger system consists of a reusable warming unit and single-use disposable warming blankets for use before, during and after surgery. This medical device launched in 1987 and is currently manufactured by the 3M Company.

<span class="mw-page-title-main">Integra LifeSciences</span> Device manufacturing company

Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.